Actively Recruiting

Phase 4
Age: 18Years +
All Genders
NCT07084441

Comparison of Outcomes of Management of Bowel Obstruction

Led by University of Washington · Updated on 2026-05-07

550

Participants Needed

4

Research Sites

251 weeks

Total Duration

On this page

Sponsors

U

University of Washington

Lead Sponsor

N

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborating Sponsor

AI-Summary

What this Trial Is About

The Comparison of Outcomes of Management of Bowel Obstruction (COMBO) trial is a patient-level randomized trial of a short course of dexamethasone + supportive care vs supportive care alone for patients with adhesion-related small bowel obstruction (aSBO). The goal of the COMBO trial is to answer the question: Can Dexamethasone increases the proportion of patients with resolution of aSBO with non-operative management (without complication) based on an established minimal important clinical difference.

CONDITIONS

Official Title

Comparison of Outcomes of Management of Bowel Obstruction

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults 18 years of age or older recruited from UWMC
  • Patients presenting to surgical services through the Emergency Department with diagnosis of SBO, consulted by surgeon, and urgent or emergency operation deemed not necessary
  • Diagnosis of adhesive small bowel obstruction established by CT findings, signs and symptoms consistent with SBO, and adhesions from prior abdominopelvic surgery as likely cause
  • Ability to provide written or electronic informed consent in English and answer teach-back questions
Not Eligible

You will not qualify if you...

  • Signs and symptoms of peritonitis with emergency operation planned
  • Planned urgent operation within the next 12 hours
  • Allergy to dexamethasone
  • Surgery within prior 6 weeks
  • Unable or unwilling to return or be contacted for and/or complete research surveys
  • Currently incarcerated in a detention facility or in police custody at baseline/screening
  • Individuals with latent infections who have an increased risk of infection

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 4 locations

1

Columbia University Medical Center

New York, New York, United States, 10032

Actively Recruiting

2

Harborview Medical Center

Seattle, Washington, United States, 98104

Actively Recruiting

3

UW Medical Center - Northwest

Seattle, Washington, United States, 98133

Actively Recruiting

4

University of Washington Medical Center Montlake

Seattle, Washington, United States, 98195

Actively Recruiting

Loading map...

Research Team

K

Kelsey Pullar, MPH

CONTACT

E

Erin Fannon

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here